Edwards Lifesciences Corporation Gain (Loss) on Investments
Edwards Lifesciences Corporation (EW) reported Gain (Loss) on Investments of -$3.50 million for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-05-06.
Financial Statements › Income Statement › Other Income
us-gaap:GainLossOnInvestments · last filed 2026-05-06
- Edwards Lifesciences Corporation gain (loss) on investments for the quarter ending 2026-03-31 was -$3.50M.
- Edwards Lifesciences Corporation gain (loss) on investments for the quarter ending 2025-03-31 was -$12.50M, a 1350.00% decline year-over-year.
- Edwards Lifesciences Corporation gain (loss) on investments for the quarter ending 2024-03-31 was $1.00M.
- Edwards Lifesciences Corporation gain (loss) on investments for the quarter ending 2023-12-31 was $4.30M.
- Edwards Lifesciences Corporation gain (loss) on investments for fiscal 2024 was $5.20M.
- Edwards Lifesciences Corporation gain (loss) on investments for fiscal 2023 was -$100.00K.
- Edwards Lifesciences Corporation gain (loss) on investments for fiscal 2022 was -$51.50M, a 239.95% decline from fiscal 2021.
- Edwards Lifesciences Corporation gain (loss) on investments for fiscal 2021 was $36.80M, a 73.58% increase from fiscal 2020.
| Period end | Gain (Loss) on Investments 3 month | Gain (Loss) on Investments 3 month as first filed | Gain (Loss) on Investments 6 month | Gain (Loss) on Investments 6 month as first filed | Gain (Loss) on Investments 9 month | Gain (Loss) on Investments 9 month as first filed | Gain (Loss) on Investments 12 month |
|---|---|---|---|---|---|---|---|
| 2026-03-31 | -$3.50M 10-Q · filed 2026-05-06 | ||||||
| 2025-03-31 | -$12.50M 10-Q · filed 2026-05-06 | ||||||
| 2024-12-31 | $5.20M 10-K · filed 2025-02-28 | ||||||
| 2024-03-31 | $1.00M 10-Q · filed 2025-05-06 | $5.30M derived: sum of 2 quarters · filed 2025-05-06 | -$2.60M derived: sum of 3 quarters · filed 2025-05-06 | ||||
| 2023-12-31 | $4.30M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | -$3.60M derived: sum of 2 quarters · filed 2025-02-28 | -$100.00K 10-K · filed 2025-02-28 | ||||
| 2023-09-30 | -$7.90M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-10-27 | -$4.40M 10-Q · filed 2023-10-27 | |||||
| 2023-06-30 | $3.50M 10-Q · filed 2023-07-28 | ||||||
| 2022-12-31 | -$2.40M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | -$13.30M derived: sum of 2 quarters · filed 2025-02-28 | -$51.50M 10-K · filed 2025-02-28 | ||||
| 2022-09-30 | -$10.90M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-10-27 | -$49.10M 10-Q · filed 2023-10-27 | |||||
| 2022-06-30 | -$38.20M 10-Q · filed 2023-07-28 | ||||||
| 2021-12-31 | $11.20M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-12 | $19.90M derived: sum of 2 quarters · filed 2024-02-12 | $36.80M 10-K · filed 2024-02-12 | ||||
| 2021-09-30 | $8.70M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-10-28 | $25.60M 10-Q · filed 2022-10-28 | |||||
| 2021-06-30 | $16.90M 10-Q · filed 2022-07-29 | ||||||
| 2020-12-31 | $21.20M 10-K · filed 2023-02-13 | ||||||
| 2017-06-30 | $2.20M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-07-28 | $3.70M 10-Q · filed 2017-07-28 | |||||
| 2017-03-31 | $1.50M 10-Q · filed 2017-04-28 | ||||||
| 2016-09-30 | $1.40M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-10-28 | $2.10M derived: sum of 2 quarters · filed 2017-07-28 | $2.40M 10-Q · filed 2016-10-28 | ||||
| 2016-06-30 | $700.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-07-28 | $1.00M 10-Q · filed 2017-07-28 | |||||
| 2016-03-31 | $300.00K 10-Q · filed 2017-04-28 | ||||||
| 2015-09-30 | $1.10M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-10-28 | $1.40M derived: sum of 2 quarters · filed 2016-10-28 | $2.50M 10-Q · filed 2016-10-28 | ||||
| 2015-06-30 | $300.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-07-29 | $1.40M 10-Q · filed 2016-07-29 | |||||
| 2015-03-31 | $1.10M 10-Q · filed 2016-04-29 | ||||||
| 2014-09-30 | -$1.90M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-10-29 | -$100.00K derived: sum of 2 quarters · filed 2015-10-29 | -$2.80M 10-Q · filed 2015-10-29 | -$3.90M 10-Q · filed 2014-10-31 | |||
| 2014-06-30 | $1.80M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-07-29 | -$900.00K 10-Q · filed 2015-07-29 | -$3.30M 10-Q · filed 2014-08-04 | ||||
| 2014-03-31 | -$2.70M 10-Q · filed 2015-04-29 | -$3.60M 10-Q · filed 2014-05-02 | |||||
| 2013-09-30 | $600.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-10-31 | $500.00K derived: sum of 2 quarters · filed 2014-10-31 | $1.00M 10-Q · filed 2014-10-31 | ||||
| 2013-06-30 | -$100.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-04 | $400.00K 10-Q · filed 2014-08-04 | |||||
| 2013-03-31 | $500.00K 10-Q · filed 2014-05-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| STERIS plc (STE) | Ireland | $20.343B | 25.49 |
| ZIMMER BIOMET HOLDINGS, INC. (ZBH) | United States | $17.103B | 20.66 |
| ALIGN TECHNOLOGY INC (ALGN) | United States | $10.346B | 29.06 |
| MSA Safety Inc (MSA) | United States | $7.023B | 21.47 |
| ESTABLISHMENT LABS HOLDINGS INC. (ESTA) | $1.954B | -65.76 | |
| Cadre Holdings, Inc. (CDRE) | United States | $1.123B | 33.88 |
| Enovis CORP (ENOV) | United States | $1.053B | -1.18 |
| Anteris Technologies Global Corp. (AVR) | United States | $0.746B | |
| Sanara MedTech Inc. (SMTI) | United States | $0.323B | -6.81 |
| Inogen Inc (INGN) | United States | $0.139B | -7.00 |